Want to join the conversation?
$VIPS 2Q15 PR: Total net revenue increased by 77.6% to RMB9Bil or $1.5Bil from RMB5.1Bil or $829.5MM in the prior year period. Gross profit increased by 78.6% to RMB2.3Bil or $363MM from RMB1.3Bil or $205.8MM in the prior year period. Gross margin increased to 25% from 24.8% in 2Q14.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.